Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose titrated amitriptyline for irritable bowel syndrome as second-line treatment
ISRCTN48075063Phase 3Completed
- Sponsor
- University of Leeds
- Start
- Nov 2019
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in irritable bowel syndrome (IBS) comparing Amitriptyline with Placebo (2 arms). Primary endpoint: Global symptoms of irritable bowel syndrome. Started Nov 2019; status: completed.
02
Drugs
amitriptyline
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on ISRCTN48075063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN48075063.